165 related articles for article (PubMed ID: 26341131)
1. Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System.
Castle JR; El Youssef J; Bakhtiani PA; Cai Y; Stobbe JM; Branigan D; Ramsey K; Jacobs P; Reddy R; Woods M; Ward WK
Diabetes Care; 2015 Nov; 38(11):2115-9. PubMed ID: 26341131
[TBL] [Abstract][Full Text] [Related]
2. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
[TBL] [Abstract][Full Text] [Related]
3. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
[TBL] [Abstract][Full Text] [Related]
4. Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
Ranjan A; Nørgaard K; Tetzschner R; Steineck IIK; Clausen TR; Holst JJ; Madsbad S; Schmidt S
Diabetes Care; 2018 Apr; 41(4):797-806. PubMed ID: 29358493
[TBL] [Abstract][Full Text] [Related]
5. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes.
Castle JR; Engle JM; El Youssef J; Massoud RG; Yuen KC; Kagan R; Ward WK
Diabetes Care; 2010 Jun; 33(6):1282-7. PubMed ID: 20332355
[TBL] [Abstract][Full Text] [Related]
6. Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study.
Haymond MW; Redondo MJ; McKay S; Cummins MJ; Newswanger B; Kinzell J; Prestrelski S
Diabetes Care; 2016 Mar; 39(3):465-8. PubMed ID: 26861921
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.
El Youssef J; Castle JR; Bakhtiani PA; Haidar A; Branigan DL; Breen M; Ward WK
Diabetes Care; 2014 Nov; 37(11):3054-60. PubMed ID: 25139882
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
9. A coordinated control strategy for insulin and glucagon delivery in type 1 diabetes.
Herrero P; Bondia J; Oliver N; Georgiou P
Comput Methods Biomech Biomed Engin; 2017 Oct; 20(13):1474-1482. PubMed ID: 28929796
[TBL] [Abstract][Full Text] [Related]
10. A bihormonal closed-loop artificial pancreas for type 1 diabetes.
El-Khatib FH; Russell SJ; Nathan DM; Sutherlin RG; Damiano ER
Sci Transl Med; 2010 Apr; 2(27):27ra27. PubMed ID: 20393188
[TBL] [Abstract][Full Text] [Related]
11. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas.
Russell SJ; El-Khatib FH; Nathan DM; Magyar KL; Jiang J; Damiano ER
Diabetes Care; 2012 Nov; 35(11):2148-55. PubMed ID: 22923666
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine.
El-Khatib FH; Jiang J; Damiano ER
J Diabetes Sci Technol; 2009 Jul; 3(4):789-803. PubMed ID: 20144330
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.
Bakhtiani PA; El Youssef J; Duell AK; Branigan DL; Jacobs PG; Lasarev MR; Castle JR; Ward WK
J Diabetes Complications; 2015; 29(1):93-8. PubMed ID: 25264232
[TBL] [Abstract][Full Text] [Related]
15. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
Rickels MR; Ruedy KJ; Foster NC; Piché CA; Dulude H; Sherr JL; Tamborlane WV; Bethin KE; DiMeglio LA; Wadwa RP; Ahmann AJ; Haller MJ; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
Diabetes Care; 2016 Feb; 39(2):264-70. PubMed ID: 26681725
[TBL] [Abstract][Full Text] [Related]
16. Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas-kidney transplantation with systemic venous insulin delivery.
Stadler M; Krššák M; Jankovic D; Göbl C; Winhofer Y; Pacini G; Bischof M; Haidinger M; Saemann M; Mühlbacher F; Korbonits M; Baumgartner-Parzer SM; Luger A; Prager R; Anderwald CH; Krebs M
Clin Endocrinol (Oxf); 2014 Feb; 80(2):208-13. PubMed ID: 23302039
[TBL] [Abstract][Full Text] [Related]
17. Role of Dual-Hormone Closed-Loop Delivery System in the Future.
Bally L; Thabit H; Hovorka R
Diabetes Technol Ther; 2016 Aug; 18(8):452-4. PubMed ID: 27500812
[No Abstract] [Full Text] [Related]
18. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.
Haymond MW; Schreiner B
Diabetes Care; 2001 Apr; 24(4):643-5. PubMed ID: 11315823
[TBL] [Abstract][Full Text] [Related]
19. Normal hepatic glycogen storage after fasting and feeding in children and adolescents with type 1 diabetes.
Flück CE; Slotboom J; Nuoffer JM; Kreis R; Boesch C; Mullis PE
Pediatr Diabetes; 2003 Jun; 4(2):70-6. PubMed ID: 14655262
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.
Haymond MW; DuBose SN; Rickels MR; Wolpert H; Shah VN; Sherr JL; Weinstock RS; Agarwal S; Verdejo AS; Cummins MJ; Newswanger B; Beck RW;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2994-3001. PubMed ID: 28591776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
